Kura Oncology's market cap is currently $620.94M. The company's EPS TTM is $-2.356; its P/E ratio is ―; Kura Oncology is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.63. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -849.00K	$ -759.00K	$ -558.00K	$ -194.00K	$ 0.00
Operating Income	$ -165.80M	$ -140.62M	$ -131.82M	$ -92.09M	$ -67.48M
EBITDA	$ -164.96M	$ -139.11M	$ -129.71M	$ -91.70M	$ -67.48M
Net Income	$ -152.63M	$ -136.07M	$ -129.91M	$ -89.43M	$ -63.14M
Balance Sheet
Cash & Short-Term Investments	$ 423.96M	$ 437.99M	$ 517.96M	$ 633.32M	$ 236.89M
Total Assets	$ 448.94M	$ 456.31M	$ 534.05M	$ 647.21M	$ 241.97M
Total Debt	$ 17.20M	$ 14.02M	$ 6.88M	$ 14.98M	$ 7.50M
Net Debt	$ -20.12M	$ -37.78M	$ -83.80M	$ -310.52M	$ -18.64M
Total Liabilities	$ 51.66M	$ 36.03M	$ 27.44M	$ 36.31M	$ 23.19M
Stockholders' Equity	$ 397.27M	$ -568.81M	$ -432.97M	$ -302.50M	$ -212.88M
Cash Flow
Free Cash Flow	$ -124.99M	$ -110.69M	$ -105.70M	$ -72.00M	$ -54.76M
Operating Cash Flow	$ -124.82M	$ -110.06M	$ -104.55M	$ -69.83M	$ -54.76M
Investing Cash Flow	$ 15.56M	$ 32.63M	$ -126.83M	$ -99.94M	$ -46.33M
Financing Cash Flow	$ 94.78M	$ 38.56M	$ -3.44M	$ 469.33M	$ 111.10M

Currency in USD

Kura Oncology Earnings and Revenue History

Income Statement >

Kura Oncology Debt to Assets

Balance Sheet >

Kura Oncology Cash Flow

Cash Flow >

Kura Oncology Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing